BPC 157 is being marketed as a healing peptide for tendon injuries, joint pain, gut repair, inflammation, and recovery. The problem is that healing biology is not always simple in people with cancer The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review BPC 157 can be an effective way to support healing from a grade 2 AC joint sprain, which involves minor tearing of the joint capsule and surrounding ligaments. This peptide can help accelerate the